Aspirin reduces intrahepatic recurrence of hepatocellular carcinoma after liver transplantation
Hepatobiliary & Pancreatic Diseases International
· Elsevier
Аннотация
Publication date: Available online 10 November 2026 Source: Hepatobiliary & Pancreatic Diseases International Author(s): Jian-Feng Zhang, Zi-Qing Huang, Wen-Feng Zhu, Xin-Ru Huang, Yong Jiang, Dong-Wei Wu, Hui Tang, Shu-Hong Yi
Читать у издателя →
Цитирование
Aspirin reduces intrahepatic recurrence of hepatocellular carcinoma after liver transplantation. // Hepatobiliary & Pancreatic Diseases International. – URL: https://www.sciencedirect.com/science/article/pii/S1499387226001918?dgcid=rss_sd_all
Aspirin reduces intrahepatic recurrence of hepatocellular carcinoma after liver transplantation. Hepatobiliary & Pancreatic Diseases International. https://www.sciencedirect.com/science/article/pii/S1499387226001918?dgcid=rss_sd_all
“Aspirin reduces intrahepatic recurrence of hepatocellular carcinoma after liver transplantation.” Hepatobiliary & Pancreatic Diseases International.
@article{article47958,
title = {Aspirin reduces intrahepatic recurrence of hepatocellular carcinoma after liver transplantation},
journal = {Hepatobiliary \& Pancreatic Diseases International},
url = {https://www.sciencedirect.com/science/article/pii/S1499387226001918?dgcid=rss_sd_all}
}